Evidence map›Paper›PMID 39846050›Full record

ArticleRheumatology advances in practice2025

Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.

Saadia Sasha Ali, Christiana Demetriou, Ioannis Parodis, Ai Lyn Tan, Abraham Edgar Gracia-Ramos, Mrudula Joshi, Carlo V Caballero-Uribe, Sreoshy Saha, James B Lilleker, Arvind Nune and 11 more

Abstract read
In one paragraph

Article in Rheumatology advances in practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Saadia Sasha AliRheumatology Department, King's College Hospital, London, UK.
Christiana DemetriouUniversity of Nicosia Medical School, Epidemiology and Public Health, Nicosia, Cyprus.ORCID https://orcid.org/0000-0003-4002-2880
Ioannis ParodisDivision of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-4875-5395
Ai Lyn TanNIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.ORCID https://orcid.org/0000-0002-9158-7243
Abraham Edgar Gracia-RamosDepartment of Internal Medicine, General Hospital, National Medical Center, "La Raza", Instituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-1842-2554
Mrudula JoshiByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India.ORCID https://orcid.org/0000-0001-7312-351X
Carlo V Caballero-UribeDepartment of Medicine, Hospital Universidad del Norte, Barranquilla, Atlantico, Colombia.ORCID https://orcid.org/0000-0002-9845-8620
Sreoshy SahaMymensingh Medical College, Mymensingh, Bangladesh.ORCID https://orcid.org/0000-0001-6745-9770
James B LillekerDivision of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0002-9230-4137
Arvind NuneSouthport and Ormskirk Hospital NHS Trust, Southport, UK.ORCID https://orcid.org/0000-0002-3849-614X
John D PaulingRoyal National Hospital for Rheumatic Diseases (at Royal United Hospitals), Bath, UK.ORCID https://orcid.org/0000-0002-2793-2364
Chris WincupDepartment of Rheumatology, Division of Medicine, Rayne Institute, University College London, London, UK.ORCID https://orcid.org/0000-0002-8742-8311
Kshitij JagtapSeth Gordhandhas Sunderdas Medical College and King Edwards Memorial Hospital, Mumbai, Maharashtra, India.ORCID https://orcid.org/0000-0003-2729-737X
Dzifa DeyRheumatology Unit, Department of Medicine and Therapeutics, University of Ghana Medical School, College of Health Sciences, Accra, Ghana.ORCID https://orcid.org/0000-0002-3339-5112
Marcin MilchertDepartment of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Pomeranian Medical University, Szczecin, Poland.ORCID https://orcid.org/0000-0002-0943-8768
Oliver DistlerDepartment of Rheumatology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-0546-8310
Hector ChinoyDivision of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0001-6492-1288
Vikas AgarwalDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Latika GuptaDepartment of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.ORCID https://orcid.org/0000-0003-2753-2990
Elena NikiphorouRheumatology Department, King's College Hospital, London, UK.ORCID https://orcid.org/0000-0001-6847-3726
COVAD Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Physical function in RA is largely influenced by multiple clinical factors, however, there is a growing body of evidence that psychological state and other comorbidities also play an essential role. Using data obtained in the COVID-19 Vaccination in Autoimmune Diseases study, an international self-reported e-survey, we aimed to explore the predictive ability of sociodemographic and clinical variables on Patient-Reported Outcomes Measurement Information System Physical Function Short Form 10a (PROMIS PF-10a) in RA and to investigate variation in disease activity and functional outcomes based on country-level socio-economic parameters. Methods: Patient demographics, disease characteristics including current symptom status, functional status and treatment variables, as well as income level of the country of residence, were extracted from survey responses. PROMIS PF-10a scores were compared across country income levels. The influence of extracted variables on reversed PROMIS PF-10a scores were investigated using negative binomial univariable- and multivariable regression. Results: A total of 1342 RA patients were included in this analysis. In the optimised parsimonious predictive model for reversed PROMIS PF-10a, older age, female gender, disease duration, fatigue and pain levels were independently associated with worse physical function, whereas Asian ethnicity, higher overall physical health ratings, ability to carry out everyday activities and residing in a country with an upper-middle or high-income level were independently associated with better physical function. Conclusion: Our study highlights that clinical factors remain strong predictors of physical function in RA, irrespective of individual and country-level socio-economic differences. Interestingly, high country-level income was associated with better physical function, irrespective of individual sociodemographic and clinical factors.

Indexed as

country-level incomeCOVADe-surveypatient-reported outcome measuresphysical functionPROMISrheumatoid arthritissociodemographic factors

Identifiers

PMID39846050
PMCPMC11751688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.